Overview

Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate if liraglutide changes AUC (area under the curve) of ethinylestradiol and levonorgestrel administered as a combination contraceptive drug (Neovletta®).
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Contraceptive Agents
Contraceptives, Oral
Ethinyl Estradiol
Levonorgestrel
Liraglutide